Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Icon (ICLR)

Add to Watchlists
Create an Alert
43.94 +0.07  +0.16% NASDAQ Apr 24, 4:59PM BATS Real time Currency in USD
View Full Chart
ICLR Price Chart
View All Events

ICLR Events

Date Type Description
Mar 31 Misc Icon to Acquire Aptiv Solutions
Feb 20 Earnings Icon PLC 4Q2013 Earning Result. Estimate: 0.45.
Feb 20 Misc Icon PLC 4Q2013 Earning Result & Conference Call
Oct 24 Misc Third Quarter 2013 Earnings Conference Call
Oct 24 Earnings Third Quarter 2013 Earnings. Estimate: 0.41.
Jul 25 Misc Q2 2013 ICON Plc Earnings Conference Call
Jul 25 Earnings Q2 2013 Earnings Release. Estimate: 0.38.
Apr 25 Misc At 2:00 Pm Uk Q1 2013 Conference Call & Webcast
Apr 25 Earnings Q1 2013 Earnings Release. Estimate: 0.33.
View All Performance Charts

ICLR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Icon is up 46.86% over the last year vs S&P 500 Total Return up 21.54%, Charles River up 35.21%, and Quintiles Transnational up N/A.

Get Quote for

PDF Report for ICLR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ICLR Pro Report PDF

Portfolio Strategies Featuring ICLR

Did Icon make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ICLR Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: Ireland
  • Headquarters State/Province: N/A
  • Incorporation Country: Ireland
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Icon Plc is a contract research organization, which provides outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies. The company offers various laboratory services, such as sample analyses, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ICLR 43.94 +0.07 +0.16% 2.706B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.